Supernus Pharmaceuticals Inc (LTS:0LB2)
$ 44.83 +0.72 (+1.63%) Market Cap: 2.62 Bil Enterprise Value: 2.28 Bil PE Ratio: 0 PB Ratio: 2.44 GF Score: 89/100

Supernus Pharmaceuticals Inc (LTS:0LB2) Transcripts

  • 1